Associated Papers
The prevalence of Pfk13 polymorphism in malaria patients treated with artemisinin-based therapy: a systematic review and meta-analysis.
Hung DT et al.
Parasitology Research, 2024
High frequency of artemisinin partial resistance mutations in the great lake region revealed through rapid pooled deep sequencing.
Young NW et al.
Medrxiv : the Preprint Server for Health Sciences, 2024
Evidence of artemisinin partial resistance in North-western Tanzania: clinical and drug resistance markers study.
Ishengoma DS et al.
Medrxiv : the Preprint Server for Health Sciences, 2024
Distribution of Plasmodium falciparum K13 gene polymorphisms across transmission settings in Ghana.
Dieng CC et al.
Bmc Infectious Diseases, 2023
Screening for K13-Propeller Mutations Associated with Artemisinin Resistance in Plasmodium falciparum in Yambio County (Western Equatoria State, South Sudan).
Molina-de la Fuente I et al.
The American Journal of Tropical Medicine and Hygiene, 2023
An optimized GATK4 pipeline for Plasmodium falciparum whole genome sequencing variant calling and analysis.
Niaré K et al.
Malaria Journal, 2023
Plasmodium falciparum kelch13 polymorphisms identified after treatment failure with artemisinin-based combination therapy in Niger.
Arzika II et al.
Malaria Journal, 2023
Plasmodium falciparum K13 mutations in Africa and Asia impact artemisinin resistance and parasite fitness.
Stokes BH et al.
Elife, 2021
Kelch 13-propeller polymorphisms in Plasmodium falciparum from Jazan region, southwest Saudi Arabia.
Dafalla OM et al.
Malaria Journal, 2020
Molecular assessment of kelch13 non-synonymous mutations in Plasmodium falciparum isolates from Central African Republic (2017-2019).
Nzoumbou-Boko R et al.
Malaria Journal, 2020
Comparative structural and evolutionary analyses predict functional sites in the artemisinin resistance malaria protein K13.
Coppée R et al.
Scientific Reports, 2019
K13-propeller gene polymorphisms in Plasmodium falciparum parasite population in malaria affected countries: a systematic review of prevalence and risk factors.
Ocan M et al.
Malaria Journal, 2019
Association of mutations in the Plasmodium falciparum Kelch13 gene (Pf3D7_1343700) with parasite clearance rates after artemisinin-based treatments-a WWARN individual patient data meta-analysis.
Unknown Author
Bmc Medicine, 2019
Declining Efficacy of Artemisinin Combination Therapy Against P. Falciparum Malaria on the Thai-Myanmar Border (2003-2013): The Role of Parasite Genetic Factors.
Phyo AP et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America, 2016
[Polymorphism Analysis of Plasmodium falciparum K13 Gene Kelch Domain Associated with Resistance to Artemisinin in Yunnan Province].
Sun AM et al.
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi = Chinese Journal of Parasitology & Parasitic Diseases, 2016
A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms.
Ménard D et al.
The New England Journal of Medicine, 2016
Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola.
Kiaco K et al.
Malaria Journal, 2015
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria.
Ariey F et al.
Nature, 2014